IP Library Granted Patent US 10,428,308
Granted Patent B2
US 10,428,308 · App. 15/687,891 · Granted Oct 1, 2019

Mesoderm and definitive endoderm cell populations

Inventors: Gordon M. Keller (Toronto, CA); Paul Gadue (New York, NY)
Assignee: Icahn School of Medicine at Mount Sinai
C12N5/067C12N5/0603C12N5/0606C12N5/0607C12N2500/90C12N2501/11C12N2501/115C12N2501/12C12N2501/148C12N2501/155C12N2501/16C12N2501/385C12N2501/40C12N2501/415C12N2506/02C12N2506/03
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,428,308
App. No.
15/687,891
Granted
Oct 1, 2019
Kind
B2
Abstract

The present invention provides cell populations that are enriched for mesendoderm and mesoderm, and cell populations that are enriched for endoderm. The cell populations of the invention are useful for generating cells for cell replacement therapy. The present invention further provides a method of generating hepatocytes, cell populations enriched for hepatocytes, and a method of hepatocyte replacement therapy.

Claims (6)

1. A method of making a cell population enriched for endoderm cells comprising culturing pluripotent stem cells in the presence of activin or nodal, and Wnt, for a time sufficient to provide brach + /HNF3β + cells, and culturing said brach + /HNF3β + cells in the presence of activin and an inhibitor of Wnt signalling for a time sufficient to provide a cell population enriched for endoderm cells.

2. The method of claim 1 wherein the stem cells are cultured in the absence of serum.

3. The method of claim 1 wherein the brach + /HNF3β + cells are cultured in the absence of serum.

4. The method of claim 1 wherein the stem cells are human embryonic stem cells.

5. The method of claim 1 wherein Wnt is Wnt 3d and the inhibitor of Wnt signaling is DKK-1.

6. The method of claim 1 wherein activin is present at a concentration of at least about 30 ng/ml.

Assignments (1)
LICENSE Recorded Aug 12, 2024
From: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
To: NATIONAL INSTITUTES OF HEALTH
Reel/Frame 068563/0199 →
Continuity (6)
Continuation 15067728 · Mar 11, 2016
Continuation 14468211 · Aug 25, 2014
Continuation 13646995 · Oct 8, 2012
Continuation 11993432
Continuation 11165930 · Jun 24, 2005
Related Publication 20180155681A1 · Jun 7, 2018